文献速递肿瘤 PET/CT

化疗后脾组织细胞丰富性假瘤模拟非霍奇金淋巴瘤残留病变的FDG PET/CT表现

Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient With Non-Hodgkin Lymphoma on FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2019-01-01

一名64岁男性高级别非霍奇金淋巴瘤患者接受多药化疗后,序贯FDG PET/CT显示脾脏残留肿块伴明显FDG高摄取,怀疑为残留存活淋巴瘤;为明确治疗决策行腹腔镜脾切除术,病理诊断为罕见的化疗后脾组织细胞丰富性假瘤,该病变在FDG PET/CT上可模拟存活肿瘤。

要点

  • 化疗后脾组织细胞丰富性假瘤可表现为FDG高摄取,易误判为残留淋巴瘤。
  • 对于FDG PET/CT怀疑脾脏残留病变而治疗决策困难时,组织病理学确诊很重要。
  • 该假瘤是FDG PET/CT上模拟存活淋巴瘤的潜在陷阱。

核心结论

  • 化疗后脾组织细胞丰富性假瘤是一种罕见的、可在FDG PET/CT上模拟存活淋巴瘤的病变。

研究设计与样本

  • 单例病例报告:64岁男性高级别非霍奇金淋巴瘤患者,接受多药化疗后行序贯FDG PET/CT及腹腔镜脾切除术。

主要发现

  • Interim及治疗后序贯FDG PET/CT显示脾脏残留肿块伴明显FDG高摄取,怀疑残留存活淋巴瘤。
  • 腹腔镜脾切除标本病理符合化疗后脾组织细胞丰富性假瘤。

临床怎么用

  • 对化疗后脾脏FDG高摄取残留肿块,需警惕组织细胞丰富性假瘤可能,必要时行病理确诊以指导治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 64-year-old man was treated with multiagent chemotherapy owing to high-grade non-Hodgkin lymphoma presenting as a bulky disease involving the spleen. Interim and posttreatment sequential FDG PET/CT scans revealed a residual splenic mass showing markedly intense FDG uptake suspected of a residual viable lymphoma. To definitely decide about the appropriate treatment, a laparoscopic splenectomy was performed. Histopathologic specimen was compatible with the rare diagnosis of postchemotherapy histiocyte-rich pseudotumor of the spleen, a potential pitfall simulating viable disease on FDG PET/CT.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Hod N, Lantsberg S, Anconina R, et al. Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient With Non-Hodgkin Lymphoma on FDG PET/CT. Clin Nucl Med. 2019. PMID: 30985428. doi:10.1097/RLU.0000000000002568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。